Ramiro Sanchez insider trades: Rapport Therapeutics (RAPP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ramiro reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | RAPP | ↑ Buy | 3,600 | $27.35 | $98K | Direct | Oct 23, 2026 (0d) |
| Dec 26, 2023 | CERE | ↓ Sell | 10,000 | $42.47 | $425K | Direct | Dec 28, 2023 (2d) |
| Dec 20, 2023 | CERE | ↓ Sell | 10,152 | $41.42 | $421K | Direct | Dec 21, 2023 (1d) |
| Dec 15, 2023 | CERE | ↓ Sell | 7,500 | $41.39 | $310K | Direct | Dec 19, 2023 (4d) |
| Dec 7, 2023 | CERE | ↓ Sell | 10,000 | $41.37 | $414K | Direct | Dec 11, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RAPP insiders
Open-market trades in the last 12 months
About Ramiro Sanchez's insider trades
Ramiro Sanchez is an insider at Rapport Therapeutics (RAPP). Since Dec 7, 2023, Ramiro has reported 1 open-market purchase worth $98K and 4 sales worth $1.6M on SEC Form 4. In the last 12 months: 1 buy ($98K).
Their filings also include grants and awards (11 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RAPP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.